The hepatic venous pressure gradient: Anything worth doing should be done right von Groszmann, Roberto J., Wongcharatrawee, Suchat

Volltext

1016 LOW RATES OF NUCLEOS(T)IDE-ASSOCIATED ADVERSE EVENTS IN THE LONG-TERM EXPERIENCE WITH ENTECAVIR von Manns, M, Akarca, U.S, Chang, T.-T, Sievert, W, Yoon, S.-K, Tsai, N, Min, A, Pangerl, A, Beebe, S, Yu, M, Wongcharatrawee, S

Volltext

Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders von Chainuvati, S., Khalid, S. K., Kancir, S., Shea, M., Edwards, J., Sernyak, M., Wongcharatrawee, S., Garcia-Tsao, G.

Volltext

What do patients consider when making decisions about treatment for hepatitis C? von Fraenkel, Liana, McGraw, Sarah, Wongcharatrawee, Suchat, Garcia-Tsao, Guadalupe

Volltext

P84 Low rates of nucleos(t)ide-associated adverse events in the long-term experience with entecavir von Mason, N, Manns, M, Akarca, U, Chang, T T, Sievert, W, Yoon, S K, Tsai, N, Min, A, Pangerl, A, Beebe, S, Yu, M, Wongcharatrawee, S

Volltext

Diagnosing portal hypertension von Wongcharatrawee, Suchat, Groszmann, Roberto J.

Volltext

The interpretation of hepatic venous pressure gradient tracings - excellent interobserver agreement unrelated to experience von Tandon, Puneeta, Ripoll, Cristina, Assis, David, Wongcharatrawee, Suchat, Groszmann, Roberto J., Garcia-Tsao, Guadalupe

Volltext

Patients’ experiences related to anti-viral treatment for hepatitis C von Fraenkel, Liana, McGraw, Sarah, Wongcharatrawee, Suchat, Garcia-Tsao, Guadalupe

Volltext

Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B von Heo, Jeong, Ahn, Sang Hoon, Kweon, Young-Oh, Kim, Byung-Ho, Chan, Henry L Y, Horban, Andrzej, Wongcharatrawee, Suchat, Llamoso, Cyril, Lee, Kwan Sik

Volltext

Sa1091 Hepatitis C (HCV) Antiviral Therapy is Feasible in Patients With Active Substance use (SU) and Mental Illness (MI) and is More Likely to Occur in Those Who Receive Education... von Bari, Khurram, Augustin, Salvador, Eggers, Carol A, Hashem, Hashem J, Desai, Mayur, Shea, Martha, Wongcharatrawee, Suchat, Lim, Joseph K, Garcia-Tsao, Guadalupe

Volltext

M1901 Low Rates of Nucleos(T)Ide-Associated Adverse Events in the Long-Term Experience With Entecavir von Min, Albert D, Tsai, Naoky, Manns, Michael P, Akarca, Ulus S, Chang, Ting-Tsung, Sievert, William, Yoon, Seung Kew, Pangerl, Andreas, Beebe, Suzanne, Yu, Miao, Wongcharatrawee, Suchat

Volltext

Entecavir+adefovir versus lamivudine+adefovir or entecavir alone in lamivudine-resistant chronic hepatitis b: 96-week data from the define study von Heo, Jeong, Ahn, Sang Hoon, Kweon, Young-Oh, Kim, Byung-Ho, Chan, Sang Hoon, Horban, Young-Oh, Wongcharatrawee, Byung-Ho, Llamoso, Sang Hoon, Lee, Kwan Sik, Bargaje, Rahul

Volltext

Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand von Chainuvati, Siwaporn, Cheng, Jun, Hou, Jin Lin, Hsu, Chao Wei, Jia, Ji Dong, Komolmit, Piyawat, Kwon, So Young, Lee, Chang Hong, Li, Hong, Li, Ying, Liu, Chun Jen, Neo, Boon Leong, Peng, Cheng Yuan, Tanwandee, Tawesak, Wongcharatrawee, Suchat, Wu, Jaw Ching, Yu, Ming Lung, Zhang, Xin Xin

Volltext

Comparison of hepatitis C (HCV) treatment patterns in patients with and without mental illness (MI) and/or substance abuse (SA) von Chainuvati, Siwaporn, Khalid, Sakib K., Kancir, Susan, Shea, Martha, Edwards, Jill, Semyak, Michael, Wongcharatrawee, Suchat, Garcia-Tsao, Guadalupe

Volltext